Correction: Journal of Hematology & Oncology (2017) 10:91 https://doi.org/10.1186/s13045-017-0449-4
The original article [1] contains an error in Fig. 2C whereby there was mistaken overlap introduced in the preparation of the Bel7402 and Bel7402 control images. The corrected figure can be viewed in this correction article.
LncRNA uc.134 suppresses the proliferation, migration, and invasion of HCC in vitro and in vivo. a Growth curves of indicated HCC cells that overexpressed uc.134 compared with those of negative control cells and untransfected cells were determined with a CCK8 proliferation analysis. The mean ± SD is shown for five independent experiments. ***P < 0.001. b Representative images of colony formation assays (left panels); analysis of the number of colonies (right panels). All experiments were performed in triplicate, and results are presented as mean ± SD. ***P < 0.001. c Invasion ability of the indicated cell lines by Transwell assays. All experiments were performed in triplicate, and results are presented as mean ± SD. ***P < 0.001. d Representative images of the scratch wound-healing assay. The wound-healing percentage was analyzed with the ImageJ software. All experiments were performed in triplicate, and results are presented as mean ± SD. **P < 0.01 and ***P < 0.001. e Representative images of tumors formed in nude mice (n = 6). *P < 0.05. f Lung metastasis model generated by injecting tumor cells into the tail veins of mice. HE staining showing the number and volume of lung metastases in each group (n = 6); **P < 0.01 and ***P < 0.001
Reference
Ni W, Zhang Y, Zhan Z, et al. A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1. J Hematol Oncol. 2017;10:91. https://doi.org/10.1186/s13045-017-0449-4.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Longhua Chen and Yi Ding have contributed equally to this work
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Ni, W., Zhang, Y., Zhan, Z. et al. Correction: A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1. J Hematol Oncol 16, 51 (2023). https://doi.org/10.1186/s13045-023-01447-z
Published:
DOI: https://doi.org/10.1186/s13045-023-01447-z